Screening and Preclinical Evaluation of Novel Radiolabeled Anti-Fibroblast Activation Protein-α Recombinant Antibodies-Reference-Cited by-同舟云学术

Screening and Preclinical Evaluation of Novel Radiolabeled Anti-Fibroblast Activation Protein-α Recombinant Antibodies

Published:2022-05-24 Issue: Volume: Page:
ISSN:1084-9785
Container-title:Cancer Biotherapy and Radiopharmaceuticals
language:en
Short-container-title:Cancer Biotherapy and Radiopharmaceuticals

Author:

Xu Jianfeng¹²^ORCID,Li Shenghua³⁴,Xu Shasha⁴,Dai Juan²,Luo Zhigang²,Cui Jingjing²,Cai Fei¹²^ORCID,Geng Changran¹,Wang Zheng²,Tang Xiaobin¹

Affiliation:

1. Department of Nuclear Sciences and Technology, Nanjing University of Aeronautics and Astronautics, Nanjing, People's Republic of China.

2. JYAMS PET Research and Development Limited, Nanjing, People's Republic of China.

3. College of Life Sciences & Health, Wuhan University of Science and Technology, Wuhan, People's Republic of China.

4. Beijing Novabody Biotechnological Ltd., Beijing, People's Republic of China.

Publisher

Mary Ann Liebert Inc

Subject

Cancer Research,Pharmacology,Radiology, Nuclear Medicine and imaging,Oncology,General Medicine,Cancer Research,Pharmacology,Radiology, Nuclear Medicine and imaging,Oncology,General Medicine

Link

https://www.liebertpub.com/doi/pdf/10.1089/cbr.2021.0389

Reference37 articles.

1. Molecular cloning of fibroblast activation protein alpha, a member of the serine protease family selectively expressed in stromal fibroblasts of epithelial cancers.

2. 68Ga-FAPI PET/CT: Tracer Uptake in 28 Different Kinds of Cancer

3. The biology and function of fibroblasts in cancer

4. Radioimmunotherapy of Fibroblast Activation Protein Positive Tumors by Rapidly Internalizing Antibodies

5. Feasibility, Biodistribution and Preliminary Dosimetry in Peptide-Targeted Radionuclide Therapy (PTRT) of Diverse Adenocarcinomas using 177Lu-FAP-2286: First-in-Human Results

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Theranostics in targeting fibroblast activation protein bearing cells: Progress and challenges;Life Sciences;2023-09